Guofang Deng

southern university of science and technology

H指数:18

被引数:912

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fixed-Dose Rifapentine–Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study

固定剂量利福喷丁–异烟肼（1HP）在中国成人中用于结核病预防治疗：一项前瞻性真实世界安全性和药代动力学研究

Clinical Infectious Diseases

IF7.3

2026-04-130

Within-host population dynamics of extensively drug-resistant Mycobacterium tuberculosis revealed by an over 3-year longitudinal study

超广泛耐药<i>Mycobacterium tuberculosis</i>的宿主内种群动力学特征：一项超过3年的纵向研究

Evolution, Medicine, and Public Health

IF0

2025-07-010

OAAI

Increasing hospital administrative efficiency via optimized office automation systems: A PDCA cycle approach

通过优化办公自动化系统提高医院行政效率：基于PDCA循环的方法

PLOS ONE

IF2.6

2025-04-290

Identification and evaluation of blood transcriptional biomarker for tuberculosis screening

结核病筛查中血液转录生物标志物的鉴定与评估

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

IF4.3

2025-04-010

OAAI

Assessing the risk of TB progression: Advances in blood-based biomarker research

评估结核病进展的风险: 基于血液的生物标志物研究进展

MICROBIOLOGICAL RESEARCH

IF6.9

2025-03-010

OAAI

GranzymeAas biomarker for diagnosis in tuberculous pleural effusion

JCI INSIGHT

IF6.1

2024-12-060

SIRT7 remodels the cytoskeleton via RAC1 to enhance host resistance to Mycobacterium tuberculosis

MBIO

IF4.7

2024-10-160

OAAI

A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis

LANCET INFECTIOUS DISEASES

IF31

2024-09-010

PRE

Breathomics for diagnosing tuberculosis in diabetes mellitus patients

呼吸组学在糖尿病患者结核病诊断中的应用

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2024-08-130

OAAI

Integrating pathogen- and host-derived blood biomarkers for enhanced tuberculosis diagnosis: a comprehensive review

整合病原体和宿主来源的血液生物标志物以增强结核病诊断: 综合综述

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-090

OAAI

Myriocin enhances the clearance of M. tuberculosis by macrophages through the activation of PLIN2

Myriocin通过激活PLIN2增强巨噬细胞对结核分枝杆菌的清除

MSPHERE

IF3.1

2024-07-301

OAAI

The association between type 2 diabetes and pulmonary cavitation revealed among IGRA-positive tuberculosis patients

FRONTIERS IN MEDICINE

IF3

2023-12-060

OAAI

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]

BMC INFECTIOUS DISEASES

IF3

2023-11-270

OAAI

The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection

EMERGING MICROBES & INFECTIONS

IF7.5

2023-08-0216

OAAI

A cross-sectional study: a breathomics based pulmonary tuberculosis detection method

BMC INFECTIOUS DISEASES

IF3

2023-03-108

OAAI

Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study

BIOSCIENCE TRENDS

IF5

2023-02-286

Sleep quality and influencing factors and correlation with T-lymphocyte subpopulation counts in patients with pulmonary tuberculosis: a cross-sectional study

BMC INFECTIOUS DISEASES

IF3

2022-12-222

OAAI

Mycobacterium tuberculosis Utilizes Host Histamine Receptor H1 to Modulate Reactive Oxygen Species Production and Phagosome Maturation via the p38MAPK-NOX2 Axis

MBIO

IF4.7

2022-10-264

OAAI

Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-10-184

OAAI

A feasibility study of Covid-19 detection using breath analysis by high-pressure photon ionization time-of-flight mass spectrometry

JOURNAL OF BREATH RESEARCH

IF3.4

2022-09-1214

Guofang Deng

个人简介

教育背景

工作经历

荣誉奖项

研究方向